NFC-Enabled BFS Vials for Single-Use Injection Verification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing vaccine administration devices, particularly in developing countries, face challenges such as the reuse of non-sterile syringes leading to the spread of blood-borne diseases, and existing single-use devices have limitations in manufacturing precision, sterilization compatibility, production rates, and cost-effectiveness.
Innovation Solution
The implementation of Blow-Fill-Seal (BFS) vials integrated with fluid delivery manifolds and safety cap manifolds, which allow for a single-dose, disposable system that includes NFC-enabled verification and authentication, enabling precise manufacturing tolerances and cost-effective production while ensuring sterility and safety.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If reusable syringes are used for vaccine administration, then device cost is reduced, but infection risk and disease transmission increase
Solution Approach 1:
The patent implements single-use disposable syringe devices that are inexpensive to manufacture but eliminate infection risks associated with reusable syringes. Each syringe is designed for one-time use only, ensuring sterility and preventing disease transmission while maintaining cost-effectiveness through automated manufacturing.
2Manufacturing precision
If pre-filled single-use injection devices are manufactured via injection molding, then manufacturing precision is improved, but production rate is limited
Solution Approach 1:
The patent merges the filling and sealing operations into a single integrated Blow-Fill-Seal process, eliminating the need for separate sterilization steps and enabling continuous high-speed production while maintaining precise manufacturing tolerances through controlled molding parameters.
3Reliability
If pre-filled single-use injection devices undergo separate sterilization processes, then sterility is ensured, but production rate is limited and cost increases
Solution Approach 1:
The patent performs sterilization actions during the initial Blow-Fill-Seal manufacturing process rather than as a separate subsequent step. The sterile barrier is formed integrally with the syringe body, ensuring sterility is built-in from the start and eliminating time-consuming post-sterilization operations.
4Reliability
If pre-filled single-use injection devices are manufactured via Form-Fill-Seal process, then sterility is ensured, but manufacturing precision for hole diameters is reduced
Solution Approach 1:
The patent optimizes the Blow-Fill-Seal process parameters including temperature, pressure, and molding speed to achieve both sterile barrier formation and precise hole diameter tolerances. By controlling these parameters, the system maintains manufacturing precision while ensuring sterility through the integrated process.
Data Source
AI summary
Systems, methods and articles of manufacture provide for an injection management platform that allows the verification and management of injection event transactions involving injectors equipped with NFC or RFID chips, generating and/or reading data via such NFC or RFID chips and authorizing injections based on such data.